We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search

Clear all

Refine your search

Content type

Tags

Author

3 results found

Article

Fox Rothschild LLP | USA | 7 Aug 2011

Chief Judge sleet rules that plaintiffs' '932 patent' is not invalid for obviousness-type double patenting

By Memorandum Opinion entered by Chief Judge Gregory M. Sleet, following a five-day bench trial, in Eli Lilly and Company, et al. v. Teva Parenteral Medicines, Inc., et al., Civil Action No. 08-335-GMS (D.Del., July 28, 2011), the Court set forth its findings of fact and conclusions of law and entered judgment in favor of plaintiffs, Eli Lilly and Company and The Trustees of Princeton University, and against defendants, Teva Parenteral Medicines, Inc., APP Pharmaceuticals, LLC and Barr Laboratories, Inc.

Previous page 1 Next page